Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - prashanth vallabhajosyula
Noninvasive diagnostic for early prognosis and diagnosis of organ rejection
Method for early prediction of acute and chronic rejection of a transplanted organ by analyzing exosomes specific to transplanted organ in recipient’s biological fluids. Problem: Transplantation remains the only curative therapy for patients with end stage failure of the heart, lung, kidney, liver, and pancreatic β cells (biabetes)....
Islet β cells exosome profile as biomarker platform for early diagnosis and monitoring of diabetes
Quantitative RNA, proteomic, and metabolite profiling of islet β cells-specific exosomes in patient plasma/serum as marker for monitoring metabolic diseases, such as type I or type II diabetes, metabolic syndrome, and obesity. Problem: Metabolic disorders including type I or type II diabetes, morbid obesity, and metabolic syndrome affect...
© 2020. All Rights Reserved. Powered by